AmCad BioMed

AmCad BioMed EBITDA per Employee

EBITDA per Employee of AmCad BioMed (4188.TWO) as of Nov 1, 2026.

EBITDA per Employee

-TWD

Last updated:

EBITDA per Employee of AmCad BioMed is 2026 - TWD. EBITDA per Employee of AmCad BioMed was 2025 - TWD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

AmCad BioMed Stock analysis

What does AmCad BioMed do? AmCad BioMed Corp, headquartered in Taipei City, Taiwan, specializes in manufacturing and selling medical diagnostic software devices. The company offers products like AmCAT-UT Detection, a computer-aided detection system for thyroid ultrasound, and AmCAD-UT Diagnosis, a computer-aided diagnosis system for the same purpose. Listed on 26 December 2013, AmCad BioMed operates in Taiwan, China, and Hong Kong markets. AmCad BioMed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AmCad BioMed stock

On Eulerpool you can find the complete historical development of EBITDA per Employee AmCad BioMed since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's AmCad BioMed historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — AmCad BioMed

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — AmCad BioMed